Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Tax Provision
|
Bristol-Myers Squibb Co
Tax Provision Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Tax Provision
-$289m
|
CAGR 3-Years
49%
|
CAGR 5-Years
22%
|
CAGR 10-Years
1%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Tax Provision
-$3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-7%
|
|
|
Pfizer Inc
NYSE:PFE
|
Tax Provision
$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Tax Provision
-$1.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-1%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Tax Provision
-$596m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-12%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Tax Provision
-$1.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-4%
|
See Also
What is Bristol-Myers Squibb Co's Tax Provision?
Tax Provision
-289m
USD
-289m
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Tax Provision amounts to -289m USD.
What is Bristol-Myers Squibb Co's Tax Provision growth rate?
Tax Provision CAGR 10Y
1%
1%
Over the last year, the Tax Provision growth was 80%. The average annual Tax Provision growth rates for Bristol-Myers Squibb Co have been 49% over the past three years , 22% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
